Selected article for: "largely unknown remain and SARS infection"
Author: Yao, Xiao-Hong; Luo, Tao; Shi, Yu; He, Zhi-Cheng; Tang, Rui; Zhang, Pei-Pei; Cai, Jun; Zhou, Xiang-Dong; Jiang, Dong-Po; Fei, Xiao-Chun; Huang, Xue-Quan; Zhao, Lei; Zhang, Heng; Wu, Hai-Bo; Ren, Yong; Liu, Zhen-Hua; Zhang, Hua-Rong; Chen, Cong; Fu, Wen-Juan; Li, Heng; Xia, Xin-Yi; Chen, Rong; Wang, Yan; Liu, Xin-Dong; Yin, Chang-Lin; Yan, Ze-Xuan; Wang, Juan; Jing, Rui; Li, Tai-Sheng; Li, Wei-Qin; Wang, Chao-Fu; Ding, Yan-Qing; Mao, Qing; Zhang, Ding-Yu; Zhang, Shu-Yang; Ping, Yi-Fang; Bian, Xiu-Wu
Title: A cohort autopsy study defines COVID-19 systemic pathogenesis
  • Cord-id: crikqy6g
  • Document date: 2021_6_16
    • ID: crikqy6g
    Snippet: Severe COVID-19 disease caused by SARS-CoV-2 is frequently accompanied by dysfunction of the lungs and extrapulmonary organs. However, the organotropism of SARS-CoV-2 and the port of virus entry for systemic dissemination remain largely unknown. We profiled 26 COVID-19 autopsy cases from four cohorts in Wuhan, China, and determined the systemic distribution of SARS-CoV-2. SARS-CoV-2 was detected in the lungs and multiple extrapulmonary organs of critically ill COVID-19 patients up to 67 days aft
    Document: Severe COVID-19 disease caused by SARS-CoV-2 is frequently accompanied by dysfunction of the lungs and extrapulmonary organs. However, the organotropism of SARS-CoV-2 and the port of virus entry for systemic dissemination remain largely unknown. We profiled 26 COVID-19 autopsy cases from four cohorts in Wuhan, China, and determined the systemic distribution of SARS-CoV-2. SARS-CoV-2 was detected in the lungs and multiple extrapulmonary organs of critically ill COVID-19 patients up to 67 days after symptom onset. Based on organotropism and pathological features of the patients, COVID-19 was divided into viral intrapulmonary and systemic subtypes. In patients with systemic viral distribution, SARS-CoV-2 was detected in monocytes, macrophages, and vascular endothelia at blood–air barrier, blood–testis barrier, and filtration barrier. Critically ill patients with long disease duration showed decreased pulmonary cell proliferation, reduced viral RNA, and marked fibrosis in the lungs. Permanent SARS-CoV-2 presence and tissue injuries in the lungs and extrapulmonary organs suggest direct viral invasion as a mechanism of pathogenicity in critically ill patients. SARS-CoV-2 may hijack monocytes, macrophages, and vascular endothelia at physiological barriers as the ports of entry for systemic dissemination. Our study thus delineates systemic pathological features of SARS-CoV-2 infection, which sheds light on the development of novel COVID-19 treatment.

    Search related documents:
    Co phrase search for related documents
    • activation status and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • activation status and local systemic: 1, 2
    • acute ards respiratory distress syndrome and local systemic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute ards respiratory distress syndrome and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acute ards respiratory distress syndrome and lung monocyte: 1, 2, 3
    • acute ards respiratory distress syndrome and lung physiological barrier: 1
    • acute respiratory syndrome and additional caution: 1, 2
    • acute respiratory syndrome and local systemic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung monocyte: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome and lung physiological barrier: 1
    • local systemic and low mortality: 1, 2
    • local systemic and lung monocyte: 1